Related Experiment Video
Updated: Jun 19, 2026
High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays (MEA)
Published on: September 13, 2012
Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery
Alexander Philipp1, Xiaobin Zhao, Peter Tarcha
1Center for Drug Research, Department of Pharmacy, Pharmaceutical Biology-Biotechnology, and Center for NanoScience (CeNS), Ludwig-Maximilians-University, Butenandstr. 5-13, D-81377 Munich, Germany.
Abstract:
RNA interference is a promising therapeutic strategy for treatment of diseases, in particular, cancer. Despite a huge number of targets identified for different cancer types, there are no effective delivery strategies available so far. Polymeric delivery vehicles are often based on large macromolecules. Such approaches often lead to accumulation of toxicity and narrow therapeutic windows. In the current paper, an alternative approach is presented. Low molecular weight oligoethylenimine (OEI) 800 Da was hydrophobically modified through the Michael addition of different alkyl acrylates. An optimal structure containing ten hexyl acrylate residues per one OEI chain (OEI-HA-10) was found to be a promising candidate for siRNA delivery. Hydrophobic modification stabilized the siRNA polyplex structure, increased the colloidal stability of the nanoparticles, and provided lytic properties to OEI required for crossing cellular membranes in the delivery process. In addition, the acrylate ester bond enables fast degradation of OEI-HA-10 into far less toxic components. Further improvement of biological properties of the OEI-HA-10 polyplexes by different formulation strategies was demonstrated. In particular, a remarkable increase of biocompatibility without loss of efficiency could be achieved by coformulation of OEI-HA-10 with lauryl acrylate modified OEI-LA-5.
Insights
Researchers developed a novel hydrophobic modification of low molecular weight oligoethylenimine (OEI) for enhanced small interfering RNA (siRNA) delivery. This approach improves nanoparticle stability, cellular uptake, and biocompatibility for potential cancer therapeutics.
Area of Science:
- Biochemistry
- Materials Science
- Nanotechnology
Background:
- RNA interference (RNAi) shows therapeutic potential for diseases like cancer.
- Effective delivery vehicles for RNAi therapeutics, particularly small interfering RNA (siRNA), are lacking.
- Conventional polymeric delivery systems often exhibit toxicity and narrow therapeutic windows.
Purpose of the Study:
- To develop a novel, low-toxicity delivery system for siRNA.
- To enhance the stability and cellular delivery of siRNA using modified oligoethylenimine (OEI).
- To improve the biocompatibility of siRNA delivery vehicles.
Main Methods:
- Hydrophobic modification of low molecular weight OEI (800 Da) via Michael addition of alkyl acrylates.
- Synthesis and characterization of an optimal OEI structure (OEI-HA-10) with ten hexyl acrylate residues.
- Evaluation of OEI-HA-10 polyplexes for siRNA delivery, including stability, cellular uptake, and degradation properties.
- Coformulation of OEI-HA-10 with OEI-LA-5 to assess improvements in biological properties.
Main Results:
- Hydrophobic modification of OEI with hexyl acrylate (OEI-HA-10) stabilized siRNA polyplexes and nanoparticles.
- OEI-HA-10 demonstrated enhanced colloidal stability and lytic properties for cellular membrane crossing.
- The acrylate ester bond facilitated rapid degradation of OEI-HA-10 into less toxic components.
- Coformulation with OEI-LA-5 significantly improved biocompatibility without compromising siRNA delivery efficiency.
Conclusions:
- Hydrophobically modified OEI (OEI-HA-10) represents a promising platform for safe and effective siRNA delivery.
- The developed system overcomes limitations of traditional polymeric carriers, offering improved stability and reduced toxicity.
- Further formulation strategies, like coformulation, can optimize the biological performance of these novel delivery vehicles.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi